Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q9UID6 (
Kruppel-like
)
147
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transcription from the HIV-1 LTR promoter efficiently initiates but rapidly terminates because of a non-processive form of RNA polymerase II. This premature termination is overcome by assembly of an HIV-1
TAT
/P-TEFb complex at the transactivation response region (TAR), a structured RNA element encoded by the first 59 nt of HIV-1 mRNA. Here we have identified a conserved DNA-binding element for the cellular transcription factor,
ZASC1
, in the HIV-1 core promoter immediately upstream of TAR. We show that
ZASC1
interacts with
TAT
and P-TEFb, co-operating with
TAT
to regulate HIV-1 gene expression, and promoting HIV-1 transcriptional elongation. The importance of
ZASC1
to HIV-1 transcription elongation was confirmed through mutagenesis of the
ZASC1
binding sites in the LTR promoter, shRNAs targeting
ZASC1
and expression of dominant negative
ZASC1
. Chromatin immunoprecipitation analysis revealed that
ZASC1
recruits Tat and P-TEFb to the HIV-1 core promoter in a TAR-independent manner. Thus, we have identified
ZASC1
as novel regulator of HIV-1 gene expression that functions through the DNA-dependent, RNA-independent recruitment of
TAT
/P-TEFb to the HIV-1 promoter.
...
PMID:ZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter. 2420 63